The safety of antidepressant drugs during pregnancy

@article{Klln2007TheSO,
  title={The safety of antidepressant drugs during pregnancy},
  author={B. K{\"a}ll{\'e}n},
  journal={Expert Opinion on Drug Safety},
  year={2007},
  volume={6},
  pages={357 - 370}
}
  • B. Källén
  • Published 2007
  • Medicine
  • Expert Opinion on Drug Safety
    • This article discusses known or suspected effects of maternal use of antidepressants during pregnancy on pregnancy outcome. It is unlikely that any marked teratogenic effect occurs with the possible exception of an increased risk for cardiovascular defects after maternal use of clomipramine or paroxetine. An increased risk for preterm birth is seen. Transient neonatal symptoms are common after the use of antidepressants in late pregnancy. Few firm data are available on the possible impact on… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    30 Citations
    Highly Influencial Citations
    1
    Background Citations
    8
    Methods Citations
    2
    Results Citations
    1
    30 Citations
    Citation Type

    Citation Type

    Maternal Use of Antidepressants and Infant Congenital Malformations
    [SSRIs and pregnancy: a review of the literature].
    • 4
    Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.
    • 295
    Managing unipolar depression in pregnancy
    • 13
    Antidepressant use in pregnancy
    • 28
    Maternal Use of Antipsychotics in Early Pregnancy and Delivery Outcome
    • 184
    Fetal exposure to neurotropic drugs : neonatal effects and long-term outcome
    Antidepressant Use During Pregnancy and Asthma in the Offspring
    • 10
    • PDF
    Maternal use of selective serotonin re‐uptake inhibitors and persistent pulmonary hypertension of the newborn
    • 165
    Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth Restriction
    • 71

    References

    SHOWING 1-10 OF 104 REFERENCES
    Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.
    • 119
    The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feeding: A Review and Clinical Aspects
    • 118
    Delivery outcome after the use of antidepressants in early pregnancy
    • 286
    Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
    • 262
    Birth outcomes after prenatal exposure to antidepressant medication.
    • 199
    Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
    • 315
    • PDF
    Perinatal outcome following third trimester exposure to paroxetine.
    • 192
    • PDF
    Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants
    • 108
    First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    • 263
    Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
    • 207
    • Highly Influential